Radiopharmaceuticals have been steadily gaining recognition in medical imaging and targeted therapies. These pharmaceutical agents contain radioactive isotopes that emit radiation, which specialised imaging devices can detect. The FDA has approved several radiopharmaceuticals for various applications, including diagnosis, treatment evaluation, and therapy. One of the most well-known FDA-approved radiopharmaceuticals is Technetium-99m, used since the 1960s. This versatile agent can be incorporated into various compounds to target specific organs or physiological systems. Technetium-99m is primarily employed in single-photon emission computed tomography (SPECT) imaging to assess the function of organs such as the heart, lungs, and brain and to detect cancer metastases. Another important radiopharmaceutical is Fluorine-18 fluorodeoxyglucose (FDG), a positron emission tomography (PET) imaging standard. FDG accumulates in cells with high glucose metabolism, making it particularly useful for identifying tumours, as cancer cells are known for their increased metabolic activity. This agent has revolutionised cancer diagnosis, staging, and treatment response evaluation. Gallium-68 Dotatate is another FDA-approved radiopharmaceutical used in PET imaging. It specifically binds to somatostatin receptors, which are overexpressed in neuroendocrine tumours. This selective binding allows for accurate tumour localisation, disease staging, and monitoring of treatment response in patients with neuroendocrine tumours. In addition to diagnostic applications, radiopharmaceuticals have also shown potential in targeted therapies. Lutetium-177 Dotatate, for instance, is an FDA-approved peptide receptor radionuclide therapy (PRRT) that targets somatostatin receptor-positive neuroendocrine tumours. This therapeutic radiopharmaceutical minimises damage to healthy tissue and has demonstrated improved progression-free survival in clinical trials by delivering targeted radiation directly to the tumour site. Another example of a therapeutic radiopharmaceutical is Radium-223 dichloride, which is approved for treating metastatic castration-resistant prostate cancer with bone metastases. Radium-223 mimics calcium and selectively targets areas of bone metastases, delivering alpha radiation to cancer cells while sparing surrounding healthy tissue. Iodine-131 is a well-established therapeutic radiopharmaceutical used to treat hyperthyroidism and thyroid cancer. It accumulates in thyroid tissue, emitting beta radiation that destroys the overactive or cancerous cells, thus restoring normal thyroid function or eliminating malignant tissue. The FDA-approved radiopharmaceuticals mentioned above represent only a fraction of the growing field. Ongoing research and development of novel radiopharmaceuticals hold immense potential for improving the accuracy of disease diagnosis, monitoring treatment response, and providing targeted therapies for various conditions. As our understanding of molecular biology advances, so will the development of innovative radiopharmaceuticals that can revolutionise modern medicine.
Last Updated: 04NOV2023
You are here:
home »
Zevalin, combining monoclonal antibodies and radiation, offers hope against refractory B-cell non-Hodgkin’s lymphoma with targeted therapy.
Yttrium-90 chloride is pivotal in radioimmunotherapy, targeting cancer cells precisely while minimizing damage to surrounding tissues.
Yttrium-90 Chloride: A Vital Component in Radioimmunotherapy Read Post »
Xenon-133 is pivotal for imaging lungs and assessing brain flow, enhancing diagnoses in modern medicine.
Xenon-133: A Radiographic Cornerstone in Pulmonary and Cerebral Diagnostic Imaging Read Post »
Thallium-201 chloride is pivotal in myocardial perfusion imaging, diagnosing ischemic heart disease, and assessing myocardial viability.
Lymphoseek offers targeted, efficient sentinel lymph node mapping, improving cancer staging and reducing surgical morbidity.
Technetium-99m tetrofosmin is vital for detecting coronary artery disease via myocardial perfusion imaging, enhancing cardiac care.
Technetium-99m sulfur colloid provides critical diagnostics for liver, spleen, and bone marrow using targeted nuclear imaging.
The Role of Technetium-99m Sulfur Colloid in Diagnostic Imaging Read Post »
Technetium-99m succimer is pivotal for renal imaging, enhancing diagnostics with minimal invasiveness and low radiation.
Technetium-99m sodium pertechnetate is pivotal for brain, thyroid, cardiac imaging, and cancer detection in nuclear medicine.
Multifaceted Role of Technetium-99m Sodium Pertechnetate in Diagnostic Imaging Read Post »
Technetium-99m Sestamibi revolutionises cardiac care by precisely mapping blood flow in diagnosing coronary artery disease.
Technetium-99m UltraTag RBCs enhance blood pool imaging and precisely localize gastrointestinal bleeding in non-invasive diagnostic procedures.
Technetium-99m pyrophosphate is pivotal for diagnosing bone diseases and cardiac amyloidosis through targeted radiopharmaceutical imaging.
Technetium-99m Pyrophosphate (Technescan PYP) in Bone Imaging and Cardiac Imaging Read Post »
Technetium-99m pentetate revolutionises brain and kidney imaging by providing crucial non-invasive insights into their function.
Technescan, utilising Technetium-99m oxidronate, revolutionises bone imaging by highlighting metabolic activity with high sensitivity and precision.
Technetium-99m Oxidronate (Technescan HDP) for Bone Imaging Read Post »
Tc-99m MAG3 scintigraphy offers unparalleled insights into renal function, aiding diagnosis and management of kidney disorders.
Technetium-99m medronate is vital in nuclear medicine for precise bone imaging and detecting osteogenesis abnormalities.
Technetium-99m Medronate (MDP-25): Bone Imaging and Osteogenesis Evaluation Read Post »
Technetium-99m Mebrofenin is pivotal for hepatobiliary imaging, assessing liver function, gallbladder diseases, and biliary obstructions.
Tc-99m MAA is pivotal in hepatobiliary imaging, providing crucial functional insights into liver and gallbladder health.
Technetium-99m exametazime (Ceretec) is a pivotal radiopharmaceutical in nuclear medicine, revolutionising brain imaging with high precision and reliability.
Posluma (Flotufolastat F-18) offers precise PET imaging for detecting PSMA-positive prostate cancer lesions.
Technetium-99m bicisate (Neurolite) facilitates stroke diagnosis by enabling cerebral perfusion imaging, aiding in locating affected brain regions.
Strontium-89 chloride: a potent palliative for metastatic bone cancer-induced pain, through calcium-mimicking, localized beta radiation, ensuring effective, safer pain relief.
Alleviating Metastatic Bone Pain: The Role of Strontium-89 Chloride in Palliative Care Read Post »
Rubidium-82 enhances PET imaging, aiding myocardial perfusion evaluation, crucial for diagnosing coronary artery disease efficiently.
Radium-223 dichloride, a targeted alpha therapy, effectively treats castration-resistant prostate cancer with bone metastases, improving patients’ overall survival.
Nitrogen-13 Ammonia, used in cardiac PET imaging, assesses myocardial perfusion, aiding diagnosis and treatment of heart diseases.
Exploring Nitrogen-13 Ammonia: A Vital Radiotracer in Cardiac Imaging and Beyond Read Post »
The Molybdenum-99 Generator crucially produces Technetium-99m for medical imaging, through radioactive decay, aiding numerous diagnostic procedures globally.
Molybdenum-99 Generator and its Impact on Medical Imaging Read Post »
Lutetium-177 Vipivotide Tetraxetan – Pluvicto: Radiopharmaceutical for targeted cancer therapy. Innovative, promising, precise, advanced, therapeutic.
Lutetium-177 Dotatate selectively binds to SSTRs on NET cells, delivering targeted radiation, minimizing collateral damage, and reducing side effects.
Lutetium-177 Dotatate: A Novel Therapeutic Approach in Neuroendocrine Tumours Read Post »
Iodine-131 sodium iodide, a radioactive isotope, is used in diagnosing and treating thyroid disorders and specific cancer therapies.
Iodine-131 Sodium Iodide: Thyroid Disorder Diagnosis and Treatment Read Post »
Iodine-131 Iobenguane (I-131 MIBG), a radiopharmaceutical agent, enables early diagnosis and targeted treatment of neuroendocrine tumours, improving patient outcomes.
Iodine-131 human serum albumin offers versatile diagnostic and therapeutic applications, despite limitations like radiation exposure and a short half-life.
Indium-111 pentetreotide excels in detecting and localising neuroendocrine tumors, monitoring treatment, and identifying therapy candidates.
Indium-111 Pentetreotide: A Valuable Tool in Nuclear Medicine Read Post »
Fluorine-18 Fluoroestradiol PET imaging enables early breast cancer detection, accurate staging, and treatment response monitoring, improving patient outcomes.
Fluorine-18 Fluoroestradiol: A Promising Tool for Breast Cancer Imaging Read Post »
Iodine-125 iothalamate, with high albumin affinity, ensures accurate GFR measurement, minimal radiation exposure, stability, and cost-effectiveness in diagnostics.
Iodine-125 Iothalamate: Diagnostic Imaging and Renal Function Read Post »
Iodine-125 Human Serum Albumin effectively measures blood volume, assesses vascular permeability, and evaluates protein-losing gastroenteropathy for accurate diagnosis.
Iodine-125 Human Serum Albumin: A Radiolabelled Diagnostic Agent Read Post »
Iodine-123 Sodium Iodide capsules aid in diagnosing thyroid disorders, providing vital insights into thyroid function and structure.
Iodine-123 Sodium Iodide Capsules: A Diagnostic Tool for Thyroid Disorders Read Post »
Iodine-123 Ioflupane known as DaTscan aids in diagnosing Parkinson’s disease by visualising dopamine transporters using SPECT imaging.
Iodine-123 Ioflupane (DaTscan): Diagnosis of Parkinson’s Disease and Movement Disorders Read Post »
Iodine-123 iobenguane is vital for detecting, staging, and monitoring neuroendocrine tumours, guiding treatment, and offering prognostic insights.
Iodine-123 Iobenguane: Diagnosis and Evaluation of Neuroendocrine Tumours Read Post »
Indium-111 Pentetate enables tumour detection, infection, inflammation tracking, and cerebrospinal fluid leak identification.
Indium-111 Pentetate: Targeted Therapy in Oncology, Infection, and Inflammation Read Post »
Indium-111 oxyquinoline enables diverse cellular imaging, crucial for detecting infections, thrombosis, tumours, and advancing stem cell research.
Indium-111 Oxyquinoline: A Versatile Radiopharmaceutical Agent Read Post »
Indium-111 chloride effectively aids infection and inflammation imaging by labelling WBCs, enabling precise issue localisation and severity assessment.
Indium-111 Chloride: A Prominent Radiotracer in Nuclear Medicine Read Post »
Gallium-68 Gozetotide enhances PET imaging for oncology, targeting somatostatin receptors, and offering improved tumour detection and patient care.
Gallium-68 Gozetotide: A Radiopharmaceutical Agent for PET Imaging Read Post »
Gallium-68 DOTATOC revolutionises neuroendocrine tumor diagnosis, enhancing PET imaging accuracy, sensitivity, and management in the medical field.
Gallium-68 DOTATOC: PET Imaging of Neuroendocrine Tumour Read Post »
Gallium-68 DOTATATE, a radiopharmaceutical, targets somatostatin receptors, aiding neuroendocrine tumor detection through PET imaging, enhancing diagnostic accuracy and patient outcomes.
Gallium-68 DOTATATE: A Novel Diagnostic Tool for Neuroendocrine Tumours Read Post »
Gallium-67 citrate is a radiopharmaceutical used for imaging infections, inflammation, cancer, and fever of unknown origin.
Gallium-67 Citrate: A Versatile Diagnostic Agent Read Post »
Fluorine-18 Flutemetamol, a radioactive tracer, for early detection of Alzheimer’s disease through PET imaging, enhancing diagnostic accuracy.
Fluorine-18 Flutemetamol: An Imaging Agent Revolutionising Alzheimer’s Disease Diagnosis Read Post »
Fluorine-18 Fludeoxyglucose, a radiotracer used in PET scans, enables precise cancer diagnosis, evaluating metabolic activity, and monitoring treatment efficacy non-invasively.
Fluorine-18 Fludeoxyglucose: A Key Radiotracer in Positron Emission Tomography Read Post »
Fluorine-18 Sodium Fluoride (18F-NaF) is an effective, safe diagnostic radiopharmaceutical, revolutionising bone imaging and detecting skeletal abnormalities with high accuracy.
Fluorine-18 Sodium Fluoride: Applications and Advantages Read Post »
Fluorine-18 Piflufolastat, a novel radiotracer, enables precise imaging of prostate cancer, enhancing diagnostic accuracy and facilitating personalied, targeted treatment approaches.
Fluorine-18 Piflufolastat: An Innovative Approach to Prostate Cancer Imaging Read Post »
Fluorine-18 Flucicovine (Axumin) improves prostate cancer detection, enabling accurate diagnosis and targeted treatments with PET imaging.
Fluorine-18 Flortaucipir: selective tau-binding radiotracer, Alzheimer’s diagnosis, PET imaging, regional limitations, off-target binding, combined diagnostic approach.
Fluorine-18 Flortaucipir: A Novel Diagnostic Tool for Alzheimer’s Disease Read Post »
Fluorine-18 Florbetapir, radiotracer, amyloid plaques, Alzheimer’s disease, PET imaging, early diagnosis, pharmaceutical research, neurodegenerative disorders, brain.
Fluorine-18 Florbetapir: An Essential Tool for Diagnosing Alzheimer’s Disease Read Post »
Fluorine-18 Florbetaben is a radiotracer used in medical imaging to detect amyloid plaques in the brain.
Fluorine-18 Florbetaben: An Advanced Radiotracer for Alzheimer’s Disease Detection Read Post »
Copper-64 DOTATE, a diagnostic radiopharmaceutical, effectively targets neuroendocrine tumours, enabling precise imaging and personalised treatment plans for cancer patients.
Carbon-14 urea, utilised in breath tests, effectively detects Helicobacter pylori infections, aiding gastric ulcer diagnosis and management.
Carbon-14 Urea: A Non-Invasive Diagnostic Tool for Gastrointestinal Disorders Read Post »
Carbon-14 Choline, a radioactive isotope, improves medical imaging accuracy and expands molecular research, aiding cancer diagnosis and treatment.
Carbon-11 Choline: A Radiopharmaceutical with Expanding Applications Read Post »
